ReleaseWire Connect

GlobalData's clinical trial report, "Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2012" provides data on the Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2012 clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2012. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2012. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData, the industry analysis specialist, has released its new report, "Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Anti-Obesity Therapeutics market. The report identifies the key trends shaping and driving the global Anti-Obesity Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Anti-Obesity Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Inflammatory Pain Global Clinical Trials Review, H1, 2012" provides data on the Inflammatory Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inflammatory Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inflammatory Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Musculoskeletal Pain Global Clinical Trials Review, H1, 2012" provides data on the Musculoskeletal Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Musculoskeletal Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Musculoskeletal Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's pharmaceuticals report, "Aromasin (Breast cancer) - Analysis and Forecasts to 2020" provides Aromasin sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the estimate period (2002-2020). The report also includes information on Breast Cancer market. This report is built using data and information sourced from GlobalData's proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

This report is the result of Canadean's extensive market and company research covering the France foodservice industry. It provides detailed analysis of both historic and forecast industry values at channel level, analysis of the leading companies in the foodservice industry and the France's business environment and landscape. The report provides a detailed study of the French foodservice industry in context of a difficult economic environment in Europe.

Recently published research from GlobalData, "Russia Power Market Outlook to 2030 - Business Propensity Indicator (BPI), Market Trends, Regulation and Competitive Landscape", is now available at Fast Market Research

The 'Packaging Annual Deal Report' will help dealmakers to effectively and efficiently gain an in-depth understanding into deal activity in the global packaging industry in 2011.

GlobalData, the industry analysis specialist, has released its new report, "Hereditary Angioedema Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Hereditary Angioedema Therapeutics market. The report identifies the key trends shaping and driving the global Hereditary Angioedema Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hereditary Angioedema Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Airlines: Global Industry Almanac is an essential resource for top-level data and analysis covering the Airlines industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.